Federal Contractor Profile
Basilea Pharmaceutica International Ag
$108M obligated·2 awards·1 agencies·1 NAICS
Federal Contracts
Showing contracts 1–12 of 12 total. Sorted by action date, most recent first. Excludes $0 modifications.
| Date | Agency | PIID | NAICS | Description | Amount |
|---|---|---|---|---|---|
| Feb 24, 2026 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 75A50123C00050 | 541714 | VENATORX PHARMACEUTICALS: NEW ANTIBIOTICS TO TREAT DRUG-RESISTANT GRAM-NEGATIVE BACTERIA INCLUDING PUBLIC HEALTH PATHOGENS. | $6.1M |
| Sep 15, 2025 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 75A50124C00033 | 541714 | THE DEVELOPMENT OF ANTIMICROBIALS FOR THE TREATMENT OF RESISTANT FUNGAL AND BACTERIAL INFECTIONS - OTA | $25M |
| Jul 7, 2025 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 75A50124C00033 | 541714 | THE DEVELOPMENT OF ANTIMICROBIALS FOR THE TREATMENT OF RESISTANT FUNGAL AND BACTERIAL INFECTIONS - OTA | $39M |
| Sep 18, 2024 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 75A50124C00033 | 541714 | THE DEVELOPMENT OF ANTIMICROBIALS FOR THE TREATMENT OF RESISTANT FUNGAL AND BACTERIAL INFECTIONS - OTA | $29M |
| Sep 28, 2022 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO100201600002C | 541711 | IGF::OT::IGF ADVANCED DEVELOPMENT OF CEFTOBIPROLE | $3.2M |
| Aug 6, 2021 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO100201600002C | 541711 | IGF::OT::IGF ADVANCED DEVELOPMENT OF CEFTOBIPROLE | $4.3M |
| Sep 16, 2020 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO100201600002C | 541711 | IGF::OT::IGF ADVANCED DEVELOPMENT OF CEFTOBIPROLE | $1.5M |
| Sep 30, 2019 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO100201600002C | 541711 | IGF::OT::IGF ADVANCED DEVELOPMENT OF CEFTOBIPROLE | $8.0M |
| Sep 11, 2018 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO100201600002C | 541711 | IGF::OT::IGF ADVANCED DEVELOPMENT OF CEFTOBIPROLE | $10M |
| Feb 14, 2018 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO100201600002C | 541711 | IGF::OT::IGF ADVANCED DEVELOPMENT OF CEFTOBIPROLE | $10M |
| Jun 6, 2017 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO100201600002C | 541711 | IGF::OT::IGF ADVANCED DEVELOPMENT OF CEFTOBIPROLE | $55M |
| Apr 19, 2016 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO100201600002C | 541711 | IGF::OT::IGF ADVANCED DEVELOPMENT OF CEFTOBIPROLE | $20M |
Get Alerted Before Basilea Pharmaceutica International Ag's Next Recompete
Mindy monitors active contracts and flags recompetes 12 months out so you can position to compete.
Start Free